# US 2026/0234684 A1 · Cell-free replication of a nucleic acid construct

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0234684 A1
- Document ID: US20260234684A1
- Status: Published application
- Kind: A1
- Application number: 19/434,624
- Filed: 2025-12-29
- Published: 2026-08-13
- Earliest claimed: 2023-06-30
- Assignees: Novel Biotechnology USA, Inc.
- Applicants: Novel Biotechnology USA, Inc.
- Inventors: Matthew WEINSTOCK
- Web page: https://patentgrep.com/patent/US20260234684A1

## CPC

- C12N 15/64: General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12Q 1/6865: Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present disclosure provides methods for cell free replication of nucleic acid constructs from template circular nucleic acid constructs that comprises rolling circle amplification of the template circular nucleic acid constructs to produce a replication product. In some instances, the present disclosure provides methods of producing a replicated circular DNA construct from the replication product using a recombinase. In some instances, the present disclosure provides methods of producing a replicated linear RNA construct from the replication product by digesting the replication product and performing in vitro transcription of the digested replication product. The disclosure also provides kits for cell-free replication of said nucleic acid constructs.

## Claims

### Claim 1

An in vitro method of producing a replicated circular DNA construct or a replicated linear RNA construct from a template circular nucleic acid construct in a cell-free system, the method comprising:
(a) providing the template circular nucleic acid construct that comprises:
(i) a target sequence comprising one or more ends;
(ii) one or more enzyme recognition sites flanking the one or more ends of the target sequence; and
(iii) a backbone sequence;
(a) contacting the template circular nucleic acid construct with a DNA polymerase configured to perform rolling circle amplification of the template circular nucleic acid via the DNA polymerase, thereby forming a replication product that comprises concatemeric replications of the target sequence and the backbone sequence joined together; and
(b) contacting the replication product with an enzyme, thereby producing the replicated circular DNA construct or the replicated linear RNA construct from the replication product; wherein:
(i) when the one or more enzyme recognition sites comprise recombination sites that flank each end of the target sequence and the enzyme is a recombinase that comprise a LoxP sequence, a Lox66 sequence, a Lox71 sequence, a FRT sequence, or a functional variant thereof, the contacting results in recombination of the replication product, which removes the backbone sequence from the replication product and joins the ends of the target sequence, thereby producing the replicated circular DNA construct; and
(ii) when the one or more enzyme recognition sites comprise one or more restriction sites flanking one or more ends of the target sequence and the enzyme is a restriction enzyme that cleaves the replication product at the one or more restriction sites, the contacting results in formation of a restriction enzyme-digested replication product, and the method further comprises contacting the restriction enzyme-digested replication product with an RNA polymerase configured to perform in vitro transcription, thereby producing the replicated linear RNA construct.

### Claim 2 (depends on 1)

The method of claim 1, wherein the DNA polymerase is a φ29, a Bst, or a Vent exo-DNA polymerase.

### Claim at position 3

-9. (canceled)

### Claim 10 (depends on 1)

The method of claim 1, wherein the recombinase is a Cre recombinase, an FLP recombinase, a lambda phage integrase, a TP901-1 lactococcal phage recombinase, a Bxb1 integrase, an R4 integrase, a Xer recombinase, a Dre recombinase, or a φC31 integrase.

### Claim at position 5

-12. (canceled)

### Claim 13 (depends on 1)

The method of claim 1, further comprising contacting the replication product with a restriction enzyme that selectively cleaves the backbone sequence prior to contacting the replication product with the recombinase, thereby forming a digested replication product for contacting with the recombinase.

### Claim 14 (depends on 1)

The method of claim 1, further comprising contacting the replication product with an exonuclease after contacting the replication product with the recombinase, wherein the exonuclease selectively digests the cleaved backbone sequence.

### Claim 15 (depends on 1)

The method of claim 1, further comprising contacting the replicated circular DNA construct with a composition that comprises one or more of:
a. a second DNA polymerase,
b. a DNA ligase,
c. a restriction enzyme, or
d. a gyrase,
wherein the contacting is in an amount and duration sufficient to repair nicks in the replicated circular DNA construct and introduce supercoiling in the replicated circular DNA construct.

### Claim 16 (depends on 1)

The method of claim 1, further comprising:
a. contacting the replicated circular DNA construct with a composition that comprises a second DNA polymerase, and a DNA ligase, wherein the contacting is in an amount and duration sufficient to repair nicks in the replicated circular DNA construct; and
b. contacting the replicated circular DNA construct with a composition that comprises a gyrase, wherein the contacting is in an amount and duration sufficient to introduce supercoiling in the replicated circular DNA construct.

### Claim 17 (depends on 1)

The method of claim 1, wherein the one or more enzyme recognition sites comprise one or more restriction sites that flank one or more ends of the target sequence, and wherein the enzyme is the restriction enzyme, thereby producing the replicated linear RNA construct.

### Claim 18 (depends on 17)

The method of claim 17, wherein the template circular nucleic acid sequence further comprises a Poly-A tail sequence adjacent to the 3′ end of the target sequence.

### Claim 19 (depends on 18)

The method of claim 18, wherein the one or more restriction sites are present on the Poly-A tail sequence.

### Claim 20 (depends on 17)

The method of claim 17, wherein the template circular nucleic acid sequence further comprises a promoter configured to interface with the RNA polymerase.

### Claim 21 (depends on 20)

The method of claim 20, wherein the RNA polymerase is a T7 RNA polymerase, and wherein the promoter is a T7 promoter.

### Claim at position 15

-25. (canceled)

### Claim 26

A kit for replicating a circular DNA construct in a cell-free system, the kit comprising:
a. a template circular nucleic acid construct that comprises:
i. a target sequence flanked by recombination sites on each end, wherein the target sequence is configured to form the circular nucleic acid construct upon recombination, and
ii. a backbone sequence;
b. a φ29, a Bst, or a Vent exo-DNA polymerase; and
c. a recombinase.

### Claim 27 (depends on 26)

The kit of claim 26, further comprising one or more of:
a. an exonuclease;
b. a DNA polymerase;
c. a DNA ligase;
d. a restriction enzyme; and
e. a gyrase.

### Claim 28 (depends on 26)

The kit of claim 26, wherein the recombinase is a Cre recombinase, an FLP recombinase, a lambda phage integrase, a TP901-1 lactococcal phage recombinase, a Bxb1 integrase, an R4 integrase, a Xer recombinase, a Dre recombinase, or a φC31 integrase.

### Claim 29

A kit for replicating a linear RNA construct in a cell-free system, the kit comprising:
a. a template circular nucleic acid construct that comprises:
i. a target sequence,
ii. a T7 promoter adjacent to the 5′ end of the target sequence, and
iii. a Poly-A tail adjacent to the 3′ end of the target sequence, wherein the Poly-A tail comprises one or more restriction enzyme sites;
b. a φ29, a Bst, or a Vent exo-DNA polymerase;
c. a restriction enzyme configured to cleave the template circular nucleic acid construct at the one or more restriction enzyme sites; and
d. a T7 RNA polymerase.

### Claim at position 20

-62. (canceled)

### Claim 63 (depends on 1)

The method of claim 1, wherein the template circular nucleic acid construct is a single-stranded template circular DNA construct.

### Claim 64

(canceled)

### Claim 65 (depends on 63)

The method of claim 63, wherein the method further comprises producing the single-stranded template circular DNA construct from a template linear DNA construct prior to 1(b); and wherein the template linear DNA construct comprises a telRL sequence on each side of the target sequence, and wherein the single-stranded template circular DNA construct is produced from the template linear DNA construct prior to (a) by contacting the template linear DNA construct with a telN protelomerase.

### Claim 66 (depends on 1)

The method of claim 1, wherein the template circular nucleic acid construct is a double-stranded template circular DNA construct.

### Claim 67

(canceled)

### Claim 68 (depends on 66)

The method of claim 66, wherein the method further comprises producing the double-stranded template circular DNA construct from a template linear DNA construct that comprises one or more ends prior to 1(b) by ligation of the ends of the template linear DNA construct.

### Claim 69

(canceled)
